"Given this, Tissue Therapies (in consultation with the Notified Body, BSI) has withdrawn its application for a Scientific Opinion in respect of VitroGro® ECM, but not the CE Mark application. Consequently, the approval (CE Mark) of Vitro Gro® ECM for the European market will be delayed."